Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Return on Sales (2016 - 2022)

Historic Return on Sales for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to 0.33%.

  • Aptevo Therapeutics' Return on Sales rose 2400.0% to 0.33% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.33%, marking a year-over-year increase of 2500.0%. This contributed to the annual value of 0.33% for FY2022, which is 2500.0% up from last year.
  • As of Q4 2022, Aptevo Therapeutics' Return on Sales stood at 0.33%, which was up 2400.0% from 0.12% recorded in Q3 2022.
  • In the past 5 years, Aptevo Therapeutics' Return on Sales ranged from a high of 0.57% in Q3 2019 and a low of 14.39% during Q2 2020
  • Its 5-year average for Return on Sales is 0.81%, with a median of 0.05% in 2020.
  • As far as peak fluctuations go, Aptevo Therapeutics' Return on Sales crashed by -126400bps in 2020, and later skyrocketed by 144300bps in 2021.
  • Aptevo Therapeutics' Return on Sales (Quarter) stood at 0.01% in 2018, then surged by 3210bps to 0.21% in 2019, then crashed by -76bps to 0.05% in 2020, then soared by 78bps to 0.09% in 2021, then skyrocketed by 267bps to 0.33% in 2022.
  • Its Return on Sales stands at 0.33% for Q4 2022, versus 0.12% for Q3 2022 and 0.07% for Q2 2022.